They've updated it. They don't particularly like the new results.
Not sure if I agree about the complaint that the data wasn't included from patients who left the trial early.
Not sure if I'm troubled by the elimination of data from sites with < 3 patients (is it really accepted practice?), even if you believe it might skew the result I can't believe all the effects would disappear.
Still, it's an alternate point of view.
Add to My Watchlist
What is My Watchlist?
